Cyberonics, Inc. (CYBX) said NYU Langone Medical Center study showed that VNS Therapy is safe and effective treatment for refractory epilepsy.
According to the company, the results showed a more than 50% reduction in seizure frequency occurred in 64.6% of patients and 42.1% of patients experienced more than a 70% reduction in seizure frequency. Patients who had failed intracranial epilepsy procedures prior to VNS Therapy had similar outcomes to those who did not have prior surgery. However, there were no significant differences in efficacy between adults and children.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.